Skip to main content
. 2021 Aug 13;14(11):2349–2355. doi: 10.1093/ckj/sfab152

FIGURE 3:

FIGURE 3:

Percentage of patients according to response status after the second and third dose of BNT162b2 in the (A) systematic and (B) conditional cohorts.